Increased Risk for Stroke, Heart Disease with Shingles

Herpes zoster may be associated with an increased long-term risk for stroke or coronary artery disease (CAD), ...

NOVEMBER 28, 2022

Shingles Vaccine Safe, Effective Up to 10 Years After Vaccination

Shingrix provides long-term protection against herpes zoster infection for at least 10 years after vaccination.

OCTOBER 21, 2022

Shingles Vaccine Does Not Appear to Increase Flares in Immunomodulator Users

The varicella zoster vaccine, Shingrix, protects against shingles in people taking immunomodulators without causing ...

SEPTEMBER 30, 2022

Reminder Calls Help Boost Shingles Vaccination Compliance

Simple phone calls help remind patients to get the second dose of a vaccine against shingles, according to new ...

OCTOBER 30, 2019

ACIP Recommends New Shingles Vaccine

The ACIP recommended Shingrix vaccine to prevent herpes zoster and its related complications in immunocompetent ...

JANUARY 29, 2018

CDC’s ACIP Recommends Adding Shingrix to the Adult Vaccination Schedule

The committee voted to include Shingrix (GlaxoSmithKline) in the adult vaccination recommendations for to prevent ...

OCTOBER 26, 2017

FDA Approves Shingrix Shingles Vaccine

Shingrix is a recombinant subunit vaccine given intramuscularly in two doses that combines an antigen, glycoprotein ...

OCTOBER 24, 2017

Shingles Increases Risk for MI, Stroke

Shingles was found to raise the risk for a composite of cardiovascular events including MI and stroke by 41%, the ...

JULY 3, 2017

Zoster Vaccine Reduces Serious Shingles Complications in Seniors, yet Remains Underused

Despite the fact that Merck’s Zostavax shingles vaccine provides seniors with high rates of protection from ...

MARCH 30, 2017